| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.4B | $2.1B | $2.2B | $1.7B | $0.4B | $0.5B | $0.4B | $0.3B |
| Net Income | $1.5B | $1.4B | $1.4B | $1.1B | $0.3B | $0.3B | $0.3B | $0.2B |
| EPS (Basic) | $7.04 | $6.78 | $6.77 | $5.53 | $1.58 | $1.42 | $1.40 | $1.05 |
| EPS (Diluted) | $7.03 | $6.77 | $6.76 | $5.52 | $1.57 | $1.42 | $1.40 | $1.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $54.1B | $48.8B | $44.8B | $42.7B | $39.7B | $45.5B | $41.9B | $36.3B |
| Current Assets | $4.3B | $3.6B | $3.5B | $4.2B | $3.3B | $3.5B | $3.1B | $3.3B |
| Cash & Equivalents | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B | $0.5B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.4B | $5.1B | $5.9B | $5.2B | $6.3B | $2.7B | $4.0B | $4.4B |
| Stockholders' Equity | $12.3B | $11.7B | $11.1B | $10.4B | $8.7B | $12.4B | $11.7B | $10.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.4B | $3.6B | $3.2B | $2.0B | $3.1B | $3.7B | $2.6B | $2.7B |
| Investing Cash Flow | $-5.3B | $-5.0B | $-4.1B | $-3.4B | $-3.9B | $-4.1B | $-5.7B | $-3.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.1B | $1.3B | $0.9B | $1.5B | $0.3B | $0.8B | $3.1B | $0.7B |